Vericel Corp Ord Stock Alpha and Beta Analysis
| VCEL Stock | USD 47.90 0.82 1.74% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Vericel Corp Ord. It also helps investors analyze the systematic and unsystematic risks associated with investing in Vericel Corp over a specified time horizon. Remember, high Vericel Corp's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Vericel Corp's market risk premium analysis include:
Beta 1.71 | Alpha 0.0407 | Risk 2.12 | Sharpe Ratio 0.0933 | Expected Return 0.2 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Vericel |
Vericel Corp Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Vericel Corp market risk premium is the additional return an investor will receive from holding Vericel Corp long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Vericel Corp. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Vericel Corp's performance over market.| α | 0.04 | β | 1.71 |
Vericel Corp expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Vericel Corp's Buy-and-hold return. Our buy-and-hold chart shows how Vericel Corp performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Vericel Corp Market Price Analysis
Market price analysis indicators help investors to evaluate how Vericel Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vericel Corp shares will generate the highest return on investment. By understating and applying Vericel Corp stock market price indicators, traders can identify Vericel Corp position entry and exit signals to maximize returns.
Vericel Corp Return and Market Media
The median price of Vericel Corp for the period between Fri, Feb 2, 2024 and Thu, May 2, 2024 is 46.26 with a coefficient of variation of 5.49. The daily time series for the period is distributed with a sample standard deviation of 2.56, arithmetic mean of 46.74, and mean deviation of 2.13. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Acquisition by Jonathan Hopper of 1750 shares of Vericel Corp subject to Rule 16b-3 | 02/20/2024 |
2 | Earnings Preview Y-mAbs Therapeutics, Inc. Q4 Earnings Expected to Decline | 02/22/2024 |
3 | Disposition of 1634 shares by Jonathan Siegal of Vericel Corp at 45.0 subject to Rule 16b-3 | 03/07/2024 |
4 | Disposition of 7874 shares by Michael Halpin of Vericel Corp at 44.71 subject to Rule 16b-3 | 03/11/2024 |
5 | Disposition of 17500 shares by Dominick Colangelo of Vericel Corp at 44.02 subject to Rule 16b-3 | 03/14/2024 |
6 | Disposition of 17500 shares by Dominick Colangelo of Vericel Corp at 44.67 subject to Rule 16b-3 | 03/18/2024 |
7 | Acquisition by Robert Zerbe of 3278 shares of Vericel Corp at 3.74 subject to Rule 16b-3 | 03/27/2024 |
8 | Global Cell and Gene Therapy Markets Report 2024-2028 Featuring Main Players - Mallinckrodt, Vericel, Gilead Sciences, Pharmicell, and Bristol-Myers Squibb | 04/03/2024 |
9 | Acquisition by Alan Rubino of 3000 shares of Vericel Corp at 4.12 subject to Rule 16b-3 | 04/09/2024 |
10 | Disposition of 17500 shares by Dominick Colangelo of Vericel Corp at 46.47 subject to Rule 16b-3 | 04/17/2024 |
11 | Disposition of 17500 shares by Dominick Colangelo of Vericel Corp at 44.59 subject to Rule 16b-3 | 04/18/2024 |
12 | Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024 | 04/24/2024 |
13 | Top Players of Hypophosphatasia Treatment Market Kirin Holdings Company, Vericel Corporation, Mereo BioPharma ... - Motions Online | 04/29/2024 |
About Vericel Corp Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Vericel or other stocks. Alpha measures the amount that position in Vericel Corp Ord has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 3.64 | 5.7 | 2.67 | 2.54 | Receivables Turnover | 4.17 | 3.53 | 3.38 | 4.8 |
Vericel Corp Upcoming Company Events
As portrayed in its financial statements, the presentation of Vericel Corp's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Vericel Corp's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Vericel Corp's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Vericel Corp. Please utilize our Beneish M Score to check the likelihood of Vericel Corp's management manipulating its earnings.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Vericel Corp
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Vericel Corp Backtesting, Vericel Corp Valuation, Vericel Corp Correlation, Vericel Corp Hype Analysis, Vericel Corp Volatility, Vericel Corp History and analyze Vericel Corp Performance. Note that the Vericel Corp Ord information on this page should be used as a complementary analysis to other Vericel Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Vericel Stock analysis
When running Vericel Corp's price analysis, check to measure Vericel Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vericel Corp is operating at the current time. Most of Vericel Corp's value examination focuses on studying past and present price action to predict the probability of Vericel Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vericel Corp's price. Additionally, you may evaluate how the addition of Vericel Corp to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Vericel Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.